- Business
- Physitrack PLC (PTRK.ST) provides digital healthcare solutions through SaaS-based platforms focused on Lifecare and Wellness segments; its core offerings include Physitrack, a remote therapeutic monitoring platform delivering exercise program prescription, patient-reported outcomes tracking, adherence monitoring, telehealth capabilities, AI-powered tools such as PhysiAssistant and Nexa MSK self-assessment, customizable home exercise programs with video libraries, outcome analysis, client onboarding features, and integrations with over 60 electronic medical records systems; and Champion Health, a corporate wellness platform combining engagement tools for emotional and physical wellbeing, telehealth coaching, proprietary wellness pathways, and localized services in markets including the UK, Sweden, and Germany. The company targets healthcare professionals in private practices, occupational health, hospitals, and sports; corporates for employee wellbeing; and public healthcare systems, operating in the United Kingdom, Europe, North America, and internationally. Founded in 2012 and headquartered at 4th Floor, 140 Aldersgate Street, London EC1A 4HY, United Kingdom, Physitrack integrates prior acquisitions such as Physiotools, PT Courses, and Champion Health while pursuing organic growth through AI enhancements, product-led sales, and market penetration in foothold and emerging regions emphasizing musculoskeletal rehabilitation, prevention, and corporate wellness. Recent developments encompass a strategic restructure of the Wellness division announced in November 2025 to prioritize high-margin SaaS growth, including divestment of non-core assets like Wellnow in March 2025 and rationalization of Champion Health operations such as clinic closures and workforce synergies to achieve EUR 0.7 million in cash flow savings in 2025; extension of a GBP 5 million revolving credit facility from Santander UK to May 2029 supporting international expansion and acquisitions; procurement by NHS trusts including Sussex Community NHS Foundation Trust and Northumbria Healthcare NHS Foundation Trust for exercise prescription services; record subscription revenue growth to 82% of total revenue with annualized recurring revenue reaching EUR 13.7 million by end-2024 alongside 18% year-on-year subscription increase; and a return to cash flow positivity in Q4 2024 with adjusted EBITDA of EUR 3.9 million at 24% margin.